In AD mice and nematode models, mitochondrial stimuli, such as NAD+ supplementation, urolithin A, and actinonin, increased PINK1 and Parkin-dependent mitophagy and alleviated AD pathology, suggesting that the removal of damaged mitochondria can act as a potential therapeutic strategy [201]. Here, PRKN is linked to Alzheimer disease.